Home / Company / Quarterly Results / Strides Pharma Science Ltd Quarterly Results

Strides Pharma Science Ltd Quarterly Results

Q2 FY26-27 Results Summary

Revenue

The revenue stands at ₹1,429.73 crore, reflecting a quarter-on-quarter *(QoQ) increase of 12.99 per cent from ₹1,265.41 crore. This corresponds to a year-on-year *(YoY) growth of 17.11 per cent.

Operating Profit

Operating Profit stands at ₹249.21 crore, reflecting a quarter-on-quarter *(QoQ) increase of 9.07 per cent from ₹228.49 crore. This corresponds to a year-on-year *(YoY) growth of 12.38 per cent.

PBDT

PBDT stands at ₹207.66 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 18.89 per cent from ₹256.02 crore. This corresponds to a year-on-year *(YoY) growth of 2.42 per cent.

Profit Before Tax

Profit Before Tax stands at ₹150.44 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 24.64 per cent from ₹199.62 crore. This corresponds to a year-on-year *(YoY) decline of 1.74 per cent.

Net Profit

Net Profit stands at ₹134.12 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 18.96 per cent from ₹165.49 crore. This represents a 1.98 per cent year-on-year *(YoY) growth for the same year.

  • YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.

Strides Pharma Science Ltd News

Smallcap 500 index hits 52-week high; Syrma, Strides, Avalon soar up to 12%

4 min read

Strides Pharma surges 11% on USFDA EIR for flagship facility in Bengaluru

4 min read

Strides sells majority stake in Pivot Path to Ascent Capital-led consortium

2 min read

Strides Pharma to sell majority stake in Pivot Path for ₹100 crore

2 min read

Strides Pharma Q4FY26 results: Net profit jumps 51% to ₹129 crore

2 min read
More

Strides Pharma Science Ltd Earnings

CategoryQ2 FY26-27Q2 FY25-26Change %FY25-26FY24-25Change %
Total Revenue1,429.731,220.8317.114,858.684,565.346.43
Expenses1,180.52999.0818.163,960.233,762.525.25
Other Income4.9827.14-81.65151.183,313.33-95.44
Operating Profit249.21221.7512.381,049.634,116.14-74.50
Depreciation57.2249.6415.27202.40192.265.27
Interest46.5446.130.89178.55248.85-28.25
Profit Before Tax150.44153.11-1.74668.693,675.03-81.80
Tax16.3221.59-24.4177.8846.9166.02
Net Profit134.12131.521.98574.523,597.51-84.03
CategoryQ2 FY26-27Q1 FY26-27Change %
Total Revenue1,429.731,265.4112.99
Expenses1,180.521,036.9213.85
Other Income4.9868.09-92.69
Operating Profit249.21228.499.07
Depreciation57.2256.401.45
Interest46.5440.5614.74
Profit Before Tax150.44199.62-24.64
Tax16.3234.13-52.18
Net Profit134.12165.49-18.96

Strides Pharma Science Ltd Research Reports

ActionTarget Price (₹)BrokerDateReports
Data Not Found

Strides Pharma Science Ltd Financial Reports

Data not available.

Strides Pharma Science Ltd Stock Prices Compare with Peers

Company1 Day1 Week1 Month3 Months6 Month1 Year
Strides Pharma-2.67%3.65%-1.27%4.02%3.66%8.63%
Corona Remedies-3.11%5.20%5.72%1.94%23.96%49.32%
Concord Biotech1.16%-4.67%-9.44%-11.84%4.20%-15.18%
Akums Drugs-1.07%6.75%-10.03%7.55%30.87%56.31%
Viyash Scientific-2.63%5.30%-5.74%-17.19%6.77%0.25%
Blue Jet Health0.17%4.03%-6.95%-14.42%5.89%-25.25%
P & G Health Ltd3.29%12.47%5.97%-12.42%10.37%-6.65%

Strides Pharma Science Ltd Corporate Information

Chairman & Non Executive Dir.: Arun Kumar
Group CEO & Executive Director: Badree Komandur
Executive Director & COO: VENKATA SEETHARAMA RAJU PAKALAPATI
Independent Non Exe. Director: Kausalya Santhanam
Independent Non Exe. Director: Mukta Malik Arora
Independent Non Exe. Director: Subir Chakraborty
Independent Non Exe. Director: Homi R Khusrokhan
Independent Non Exe. Director: Ameet Hariani
Company Sec. & Compli. Officer: Manjula Ramamurthy
Independent Director: Biren Gabhawala

Strides Pharma Science Ltd News

No More Data

More